We’re introduced to the traditional two-stroke diesel engine as thermally efficient but not smooth-running, and then the gas turbine as smooth but much more inefficient. The free piston engine ...

Eli Tomac scored the first Vancouver Supercross victory in 20 years by outrunning Ken Roczen in Round 1 of the World Supercross Championship at BC Place. Roczen won the SuperPole with a time of 50.742 ...

During the MXA YouTube video, Josh Mosiman discusses the KX450 testing revealed dyno-testing showing the bike's 449cc engine produced 57.2 horsepower ... Ryan Villopoto, and Eli Tomac being ...

The big news is that America's Eli Tomac will also participate in all four rounds to challenge Roczen for the title. Other big names on the list are ones to keep an eye out for as well.

The big news is that America's Eli Tomac will also participate in all four rounds to challenge Roczen for the title. Other big names on the list are ones to keep an eye out for as well. View the ...

App Store and the Apple logo are trademarks of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC. © carsales.com.au Pty Ltd 1999-2024 In ...

Eli Lilly and Company (LLY, Financials) said tirzepatide drastically reduced the risk of type 2 diabetes in pre-diabetics and obese or overweight people over 176 weeks; shares rose modestly after ...

Eli Tomac improved throughout the nights until he was virtually unstoppable and took out the overall win in SX1. The 2024 FIM World Supercross Championship (WSX) fired back to life at Vancouver’s BC ...

Eli Crane (R-AZ) defended his House seat from ... the race Saturday night with 90% of the vote counted. Crane has 54.2% of the vote, while Nez has 45.8%. The Cook Political Report rated Arizona ...

However, Eli Lilly continued to develop GLP-1 drugs, getting Trulicity, which is used to treat type 2 diabetes, approved in 2014. By 2018, Trulicity would become Eli Lilly's top-selling drug ...

Eli Lilly has dropped (PDF) the lead candidate from its $2.4 billion takeover of Dice Therapeutics, shifting the focus of its oral IL-17 psoriasis program to a follow-up molecule. Lilly kicked DC ...